Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Dexamethasone in Coronary Artery Bypass Patients
NCT05487508Phase 4Completed
- Sponsor
- Universitas Indonesia
- Start
- Jul 2018
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in coronary artery disease (CAD) (4 arms), sponsored by Universitas Indonesia. Primary endpoints: Presence of arrhythmia, Perioperative myocardial infarction and 5 more. Started Jul 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05487508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05487508.